Cat. No.: X24-05-ZQ435
Epigenetic reader domain inhibitor CeMMEC13, Purity ≥98%
Synonym: 1790895-25-8; CeMMEC13; 1-Methyl-2-oxo-1,2-dihydro-quinoline-4-carboxylic acid (2,3-dihydro-benzo[1,4]dioxin-6-yl)-amide; N-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1-methyl-2-oxo-1,2-dihydroquinoline-4-carboxamide; CHEMBL4871450; Epigenetic reader domain inhibitor
- CAS Number: 1790895-25-8
- Compound CID: 110694558
Product Size
5 mg; 10 mg; 50 mg
Properties
Description
CeMMEC13, soluble in DMSO and ethanol and insoluble in water, disrupts the function of proteins that recognize and bind specific epigenetic marks, affecting the interpretation of epigenetic signals.
Molecular Formula
C19H16N2O4
Solubility
DMSO: 62 mg/mL (184.33 mM); Water: Insoluble; Ethanol: 6 mg/mL (17.83 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
CeMMEC13 can be used to investigate the inhibition of the bromodomain-containing protein 4 (BRD4) in cancer and inflammation.
Related Products
Quick Links